STIM

#4006
Neuronetics, Inc. Common Stock
1.43 USD
+2.88%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
1.43
1.43
Intervallo Annuale
0.80
4.82
Variazione giornaliera
+2.88%
Variazione Mensile
+5.93%
Variazione di 6 mesi
-51.69%
Variazione Annuale
-62.37%
Chiusura Precedente
1.39
Apertura
1.43
Bid
Ask
Minimo
1.43
High
1.43
Volume
29
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 99.07 M
  • Employee 658
  • Founded 2003
  • CEO N/A
  • Website www.neurostar.com
  • Headquarter Delaware, United States
  • FIGI BBG000QX36J1
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-2.34
Rapporto prezzo/fatturato
0.65

Neuronetics Inc

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. Neuronetics became the "first and only Food and Drug Administration approval for the clinical treatment of a specific form of medication-refractory depression using a TMS Therapy device." They manufacture a transcranial magnetic stimulation device, NeuroStar. The NeuroStar TMS therapy is delivered via a precisely positioned magnetic coil against the patient's head.

Notizie